• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体重指数作为肾细胞癌静脉瘤栓血栓切除术时切除下腔静脉的独立危险因素。

Body mass index as an independent risk factor for inferior vena cava resection during thrombectomy for venous tumor thrombus of renal cell carcinoma.

机构信息

Department of Urology, Peking University Third Hospital, Beijing, China.

Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China.

出版信息

World J Surg Oncol. 2019 Jan 15;17(1):17. doi: 10.1186/s12957-019-1560-5.

DOI:10.1186/s12957-019-1560-5
PMID:30646899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6334420/
Abstract

OBJECTIVE

To define preoperative clinical and radiographic risk factors for the need of inferior vena cava (IVC) resection in patients with renal cell carcinoma (RCC) and IVC tumor thrombus.

METHODS

We reviewed data of 121 patients with renal cell carcinoma and venous tumor thrombus receiving radical nephrectomy and thrombectomy at our institution between 2015 and 2017, and 86 patients with Mayo I-IV level tumor thrombus were included in the final analysis. Clinical features, operation details, and pathology data were collected. Preoperative images were reviewed separately by two radiologists. Univariable and multivariable logistic regression analyses were applied to evaluate clinical and radiographic risk factors of IVC resection.

RESULTS

Of the 86 patients, 44 (51.2%) received IVC resection during thrombectomy. In univariate analysis, we found that body mass index (BMI) (odds ratio [OR] = 1.22, P = 0.003), primary tumor diameter (OR = 0.84, P = 0.022), tumor thrombus width (OR = 1.08, P = 0.037), tumor thrombus level (OR = 1.57, P = 0.030), and IVC occlusion (OR = 2.67, P = 0.038) were associated with the need for resection of the IVC. After adjusting for the other factors, BMI (OR = 1.18, P = 0.019) was the only significant risk factor for IVC resection. Multivariable analysis in Mayo II-IV subgroups confirmed BMI as an independent risk factor (OR = 1.26, P = 0.024). A correlation between BMI and the width (Pearson's correlation coefficient [PCC] = 0.27, P = 0.014) and length (PCC = 0.23, P = 0.037) of the tumor thrombus was noticed.

CONCLUSION

We identified BMI as an independent risk factor for IVC resection during thrombectomy of RCC with tumor thrombus in a Chinese population. More careful preoperative preparation for the IVC resection and/or reconstruction is warranted in patients with higher BMI.

摘要

目的

确定接受根治性肾切除术和血栓切除术的肾细胞癌(RCC)伴下腔静脉(IVC)肿瘤血栓患者需要切除 IVC 的术前临床和影像学危险因素。

方法

我们回顾了 2015 年至 2017 年期间在我院接受根治性肾切除术和血栓切除术的 121 例肾细胞癌伴静脉肿瘤血栓患者的数据,最终分析纳入 86 例 Mayo I-IV 级肿瘤血栓患者。收集临床特征、手术细节和病理数据。两名放射科医生分别对术前图像进行了单独审查。应用单变量和多变量逻辑回归分析评估 IVC 切除的临床和影像学危险因素。

结果

86 例患者中,44 例(51.2%)在血栓切除术时行 IVC 切除术。单因素分析发现,体质量指数(BMI)(比值比[OR] = 1.22,P = 0.003)、原发肿瘤直径(OR = 0.84,P = 0.022)、肿瘤血栓宽度(OR = 1.08,P = 0.037)、肿瘤血栓水平(OR = 1.57,P = 0.030)和 IVC 闭塞(OR = 2.67,P = 0.038)与 IVC 切除术的需要相关。在调整其他因素后,BMI(OR = 1.18,P = 0.019)是 IVC 切除的唯一显著危险因素。Mayo II-IV 亚组的多变量分析证实 BMI 是独立的危险因素(OR = 1.26,P = 0.024)。BMI 与肿瘤血栓的宽度(Pearson 相关系数[PCC] = 0.27,P = 0.014)和长度(PCC = 0.23,P = 0.037)呈正相关。

结论

我们发现 BMI 是中国人群 RCC 伴肿瘤血栓患者血栓切除术中 IVC 切除的独立危险因素。对于 BMI 较高的患者,应更仔细地进行 IVC 切除和/或重建的术前准备。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/293e/6334420/5464cc02bdee/12957_2019_1560_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/293e/6334420/0e18c56ec40e/12957_2019_1560_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/293e/6334420/edd5e3c76f5d/12957_2019_1560_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/293e/6334420/5464cc02bdee/12957_2019_1560_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/293e/6334420/0e18c56ec40e/12957_2019_1560_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/293e/6334420/edd5e3c76f5d/12957_2019_1560_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/293e/6334420/5464cc02bdee/12957_2019_1560_Fig3_HTML.jpg

相似文献

1
Body mass index as an independent risk factor for inferior vena cava resection during thrombectomy for venous tumor thrombus of renal cell carcinoma.体重指数作为肾细胞癌静脉瘤栓血栓切除术时切除下腔静脉的独立危险因素。
World J Surg Oncol. 2019 Jan 15;17(1):17. doi: 10.1186/s12957-019-1560-5.
2
Clinical and radiographic predictors of the need for inferior vena cava resection during nephrectomy for patients with renal cell carcinoma and caval tumour thrombus.肾细胞癌合并腔静脉瘤栓患者肾切除术中下腔静脉切除必要性的临床及影像学预测因素
BJU Int. 2015 Sep;116(3):388-96. doi: 10.1111/bju.13005. Epub 2015 Mar 23.
3
Preoperative metastatic status, level of thrombus and body mass index predict overall survival in patients undergoing nephrectomy and inferior vena cava thrombectomy.术前转移状态、血栓水平和体重指数可预测接受肾切除术和下腔静脉血栓切除术的患者的总生存率。
BJU Int. 2012 Dec;110(11 Pt B):E470-4. doi: 10.1111/j.1464-410X.2012.11155.x. Epub 2012 Apr 23.
4
Laparoscopic Radical Nephrectomy and Inferior Vena Cava Thrombectomy in the Treatment of Renal Cell Carcinoma.腹腔镜根治性肾切除术和下腔静脉取栓术治疗肾细胞癌。
Eur Urol. 2015 Jul;68(1):115-22. doi: 10.1016/j.eururo.2014.12.011. Epub 2014 Dec 19.
5
A Predictive Model for Tumor Invasion of the Inferior Vena Cava Wall Using Multimodal Imaging in Patients with Renal Cell Carcinoma and Inferior Vena Cava Tumor Thrombus.基于多模态影像的肾细胞癌合并下腔静脉瘤栓患者下腔静脉壁肿瘤侵犯预测模型。
Biomed Res Int. 2020 Oct 6;2020:9530618. doi: 10.1155/2020/9530618. eCollection 2020.
6
Bland thrombus association with tumour thrombus in renal cell carcinoma: analysis of surgical significance and role of inferior vena caval interruption.肾细胞癌中肿瘤栓子与无病变血栓的关系:分析手术意义及下腔静脉阻断的作用。
BJU Int. 2012 Dec;110(11 Pt B):E449-55. doi: 10.1111/j.1464-410X.2012.11128.x. Epub 2012 Apr 30.
7
Robot-assisted Laparoscopic Inferior Vena Cava Thrombectomy: Different Sides Require Different Techniques.机器人辅助腹腔镜下下腔静脉血栓切除术:不同部位需要不同的技术。
Eur Urol. 2016 Jun;69(6):1112-9. doi: 10.1016/j.eururo.2015.12.001. Epub 2015 Dec 17.
8
Surgical strategy for treating renal cell carcinoma with thrombus extending into the inferior vena cava.治疗肾细胞癌伴血栓延伸至下腔静脉的手术策略。
J Vasc Surg. 2004 Apr;39(4):829-35. doi: 10.1016/j.jvs.2003.12.004.
9
Surgical treatment of renal cell carcinoma: Can morphological features of inferior vena cava tumor thrombus on computed tomography or magnetic resonance imaging be a prognostic factor?肾细胞癌的外科治疗:计算机断层扫描或磁共振成像下腔静脉瘤栓的形态学特征能否作为预后因素?
Int J Urol. 2017 Feb;24(2):102-109. doi: 10.1111/iju.13272. Epub 2017 Jan 22.
10
Initial Series of Robotic Segmental Inferior Vena Cava Resection in Left Renal Cell Carcinoma With Caval Tumor Thrombus.机器人辅助左肾癌合并下腔静脉瘤栓节段性切除术的初步系列报道。
Urology. 2020 Aug;142:125-132. doi: 10.1016/j.urology.2020.03.053. Epub 2020 Apr 24.

引用本文的文献

1
Influence of tumor size in the progression of venous tumor thrombus in renal cell carcinoma: A 7-year single-center experience.肿瘤大小对肾细胞癌静脉瘤栓进展的影响:一项为期7年的单中心经验
Urol Ann. 2022 Jul-Sep;14(3):273-278. doi: 10.4103/UA.UA_169_20. Epub 2022 Jul 18.
2
Prognostic Significance of NLR About NETosis and Lymphocytes Perturbations in Localized Renal Cell Carcinoma With Tumor Thrombus.中性粒细胞与淋巴细胞比值对伴有肿瘤血栓的局限性肾细胞癌中细胞焦亡及淋巴细胞扰动的预后意义
Front Oncol. 2021 Dec 21;11:771545. doi: 10.3389/fonc.2021.771545. eCollection 2021.
3
Safety of subxiphoid uniportal video-assisted thoracoscopic surgery for anterior mediastinal tumour in obese patients.

本文引用的文献

1
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
2
[Radical nephrectomy and thrombectomy for Mayo clinic stage III tumor thrombus: a surgical technique and clinical experience].[梅奥诊所Ⅲ期肿瘤血栓的根治性肾切除术及取栓术:手术技术与临床经验]
Beijing Da Xue Xue Bao Yi Xue Ban. 2017 Aug 18;49(4):597-604.
3
Surgical Management and Outcome of Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus.伴有下腔静脉瘤栓的肾细胞癌的外科治疗及预后
肥胖患者剑突下单孔电视辅助胸腔镜手术治疗前纵隔肿瘤的安全性
Wideochir Inne Tech Maloinwazyjne. 2021 Jun;16(2):377-381. doi: 10.5114/wiitm.2020.100879. Epub 2020 Nov 13.
4
Removal of tumor thrombus from the azygos vein in an esophageal squamous cell carcinoma patient.一名食管鳞状细胞癌患者奇静脉肿瘤血栓的清除。
J Cardiothorac Surg. 2020 Mar 26;15(1):52. doi: 10.1186/s13019-020-01092-4.
Urol Int. 2017;99(3):267-271. doi: 10.1159/000464108. Epub 2017 Mar 3.
4
Renal cell carcinoma survival and body mass index: a dose-response meta-analysis reveals another potential paradox within a paradox.肾细胞癌生存率与体重指数:一项剂量反应荟萃分析揭示了悖论中的另一个潜在悖论。
Int J Obes (Lond). 2016 Dec;40(12):1817-1822. doi: 10.1038/ijo.2016.171. Epub 2016 Sep 30.
5
Radiologic indicators prior to renal cell cancer thrombectomy: Implications for vascular reconstruction and mortality.肾细胞癌血栓切除术之前的放射学指标:对血管重建和死亡率的影响
Urol Ann. 2016 Jul-Sep;8(3):312-6. doi: 10.4103/0974-7796.184888.
6
Advances in Robotic Vena Cava Tumor Thrombectomy: Intracaval Balloon Occlusion, Patch Grafting, and Vena Cavoscopy.机器人腔静脉肿瘤血栓切除术的进展:腔内心脏球囊阻断、补片移植和腔静脉镜检查。
Eur Urol. 2016 Nov;70(5):884-890. doi: 10.1016/j.eururo.2016.06.024. Epub 2016 Jul 19.
7
Renal cell carcinoma with thrombus extending to the hepatic veins or right atrium: operative strategies based on 41 consecutive patients.肾细胞癌伴血栓延伸至肝静脉或右心房:基于41例连续患者的手术策略
Eur J Cardiothorac Surg. 2016 Aug;50(2):317-21. doi: 10.1093/ejcts/ezw023. Epub 2016 Mar 25.
8
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.
9
Robot-assisted Laparoscopic Inferior Vena Cava Thrombectomy: Different Sides Require Different Techniques.机器人辅助腹腔镜下下腔静脉血栓切除术:不同部位需要不同的技术。
Eur Urol. 2016 Jun;69(6):1112-9. doi: 10.1016/j.eururo.2015.12.001. Epub 2015 Dec 17.
10
Risk factors for recurrence after surgery in non-metastatic RCC with thrombus: a contemporary multicentre analysis.非转移性肾细胞癌伴血栓患者术后复发的危险因素:一项当代多中心分析。
BJU Int. 2016 Jun;117(6B):E87-94. doi: 10.1111/bju.13268. Epub 2015 Oct 5.